AA0143: DYKDDDDK Peptide

Purity: > 95%
 

BP000041-MPR10: Glucose-AGE-BSA

Modified with glucose for highest biological activity.
Activity: Measured by its binding to the immobilized RAGE in an ELISA binding assay.
Extent of AGE modification: 25-30 adducts per Glucose-AGE-BSA, as judged by free amine content analysis and MALDI-TOF analysis.
Can pair with biotinylated AGE-BSA (Cat# BP000042-MPR10) for competitive ELISA.
Endotoxin: < 0.1 EU/ug AGE-BSA as determined by the LAL method.

BP000038-MPR11: Recombinant Human Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein

Source: E. Coli-derived.
Fully glycosylated and biologically active.

BP000042-MPR10: Biotin-AGE-BSA

Efficiently biotinylated while preserving full activity.
Modified with glucose for highest biologic activity.
Can pair with AGE-BSA (Cat# BP000041-MPR10) for competitive ELISA.
Activity: KD 50-20 nM, as measured by its binding to the immobilized RAGE in an ELISA binding assay.
Extent of AGE modification: 25-30 adducts per Biotin-AGE-BSA, as judged by free amine content analysis and MALDI-TOF analysis.
Extent of biotinylation: 6-7 biotins per AGE-BSA, as judged by HABA assay and MALDI-TOF analysis.
Endotoxin: < 0.1 EU/ug AGE-BSA as determined by the LAL method.

BP000040-0011: Recombinant Mouse C-C Motif Chemokine 1 (CCL1) Protein

Source: CHO cell cell-derived.
Purity: > 92% by SDS-PAGE.
Endotoxin: < 1.0 EU per ug of the protein as determined by the LAL method.
Fusion protein: Human Fc fused to the C-terminus of mouse CCL1.

BP000043-0021: Recombinant Mouse CCL2 Fc Fusion Protein

Source: CHO cell cell-derived.
Fusion protein: human Fc fused to the C-terminus of mouse CCL2.

BP000044-0031: Recombinant Mouse C-C Motif Chemokine 3 (CCL3) Protein

Source: CHO cell cell-derived.
Fusion protein: human Fc fused to the C-terminus of mouse CCL3.

BP000039-0041: Recombinant Mouse CCL4 Fc Fusion Protein

Source: CHO cell cell-derived.
Fusion protein: human Fc fused to the C-terminus of mouse CCL4.

BP000046-350: Mouse Flt3L Fc fusion protein

Source: CHO cell-derived.
Activity: Effective in generating BM-derived DC precursors (3-10 ug/ml in vitro, 10 ug per animal every 3-4 days in vivo); binds to bone marrow derived dendritic cells as shown in flow cytometry.
About 10 times more potent than native Flt3L in vitro and in vivo.
Better pharmacokinetics than native Flt3L in vivo.
Purity >90% by SDS-PAGE.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.

BP000045-360: Recombinant Mouse FLT3L

Source: CHO cell-derived.
Activity: Effective in generating BM-derived DC precursors (30-100 ug/ml in vitro; 10 ug per animal daily in vivo).
Purity >90% by SDS-PAGE.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.